patients with chronic systolic heart failure who are submitted to a cardiac resynchronization therapy device implant, with either pacemaker or implantable cardioverter-defibrillator capabilities, as a first implant or as an upgrade from a previously implanted cardiac electric device, who exhibit a normofrequent regular ventricular rhythm.